Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-09-17

Clinical Trial Update: Randomized Trial of Acetazolamide for Uveitis-Associated Cystoid Macular Edema [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial evaluating acetazolamide for uveitis-associated cystoid macular edema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Macular Edema, Cystoid | Phase 2 | Status: COMPLETED